The study compared the creatinine clearance test, the gold standard for measuring preoperative renal function, with eGFR, and found no significant differences among the tests in patients with gastric cancer.
They concluded eGFR may be used in place of Ccr due to clear medical and socioeconomic advantages, according to the release.
Read the release on eGFR use in gastric cancer patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.